131 related articles for article (PubMed ID: 34800656)
1. Oral vaccination of dogs with a monovalent live-avirulent vaccine confers 1 year of immunity against Bordetella bronchiseptica challenge.
Hainer N; Velineni S; Bowers A; Waite C; Walker J; Wilmes L; Tague A; King V; Millership J; Martorell S
Vet J; 2021 Dec; 278():105775. PubMed ID: 34800656
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of intranasal and oral vaccines against Bordetella bronchiseptica in dogs.
Ellis JA; Gow SP; Waldner CL; Shields S; Wappel S; Bowers A; Lacoste S; Xu Z; Ball E
Vet J; 2016 Jun; 212():71-7. PubMed ID: 27256028
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs.
Lehar C; Jayappa H; Erskine J; Brown A; Sweeney D; Wassmoen T
Vet Ther; 2008; 9(4):257-62. PubMed ID: 19177330
[TBL] [Abstract][Full Text] [Related]
4. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs.
Ellis JA; Haines DM; West KH; Burr JH; Dayton A; Townsend HG; Kanara EW; Konoby C; Crichlow A; Martin K; Headrick G
J Am Vet Med Assoc; 2001 Feb; 218(3):367-75. PubMed ID: 11201562
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica.
Davis R; Jayappa H; Abdelmagid OY; Armstrong R; Sweeney D; Lehr C
Vet Ther; 2007; 8(1):32-40. PubMed ID: 17447223
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs.
Ellis JA; Krakowka GS; Dayton AD; Konoby C
J Am Vet Med Assoc; 2002 Jan; 220(1):43-8. PubMed ID: 12680446
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica.
Iemura R; Tsukatani R; Micallef MJ; Taneno A
Vet Rec; 2009 Dec; 165(25):747-51. PubMed ID: 20023279
[TBL] [Abstract][Full Text] [Related]
8. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough).
Kontor EJ; Wegrzyn RJ; Goodnow RA
Am J Vet Res; 1981 Oct; 42(10):1694-8. PubMed ID: 6275747
[TBL] [Abstract][Full Text] [Related]
9. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
[TBL] [Abstract][Full Text] [Related]
10. How well do vaccines for Bordetella bronchiseptica work in dogs? A critical review of the literature 1977-2014.
Ellis JA
Vet J; 2015 Apr; 204(1):5-16. PubMed ID: 25747699
[TBL] [Abstract][Full Text] [Related]
11. A doggy tale: Risk of zoonotic infection with Bordetella bronchiseptica for cystic fibrosis (CF) patients from live licenced bacterial veterinary vaccines for cats and dogs.
Moore JE; Rendall JC; Millar BC
J Clin Pharm Ther; 2022 Feb; 47(2):139-145. PubMed ID: 34328230
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of intranasal and injectable vaccines in stimulating
Ellis JA; Gow SP; Lee LB; Lacoste S; Ball EC
Can Vet J; 2017 Aug; 58(8):809-815. PubMed ID: 28761185
[TBL] [Abstract][Full Text] [Related]
13. Intranasal vaccination of dogs with liver avirulent Bordetella bronchiseptica: correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis.
Bey RF; Shade FJ; Goodnow RA; Johnson RC
Am J Vet Res; 1981 Jul; 42(7):1130-2. PubMed ID: 7271029
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against Bordetella bronchiseptica infection in dogs using a heat-killed bacterial vaccine.
McCandlish IA; Thompson H; Wright NG
Res Vet Sci; 1978 Jul; 25(1):45-50. PubMed ID: 705048
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge.
Bradley A; Kinyon J; Frana T; Bolte D; Hyatt DR; Lappin MR
J Vet Intern Med; 2012; 26(5):1121-5. PubMed ID: 22860699
[TBL] [Abstract][Full Text] [Related]
16. Canine parainfluenza-Bordetella bronchiseptica vaccine immunogenicity.
Chladek DW; Williams JM; Gerber DL; Harris LL; Murdock FM
Am J Vet Res; 1981 Feb; 42(2):266-70. PubMed ID: 6266289
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine.
Shade FJ; Goodnow RA
Am J Vet Res; 1979 Sep; 40(9):1241-3. PubMed ID: 525927
[No Abstract] [Full Text] [Related]
18. Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hours.
Gore T; Headley M; Laris R; Bergman JG; Sutton D; Horspool LJ; Jacobs AA
Vet Rec; 2005 Apr; 156(15):482-3. PubMed ID: 15828745
[No Abstract] [Full Text] [Related]
19. Adenovirus 2, Bordetella bronchiseptica, and Parainfluenza Molecular Diagnostic Assay Results in Puppies After vaccination with Modified Live Vaccines.
Ruch-Gallie R; Moroff S; Lappin MR
J Vet Intern Med; 2016; 30(1):164-6. PubMed ID: 26692461
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to Bordetella bronchiseptica in vaccinated and infected dogs.
Ellis J; Rhodes C; Lacoste S; Krakowka S
Can Vet J; 2014 Sep; 55(9):857-64. PubMed ID: 25183893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]